<?xml version="1.0" ?>
<!DOCTYPE PubmedArticleSet PUBLIC "-//NLM//DTD PubMedArticle, 1st January 2023//EN" "https://dtd.nlm.nih.gov/ncbi/pubmed/out/pubmed_230101.dtd">
<PubmedArticleSet>
<PubmedArticle><MedlineCitation Status="MEDLINE" Owner="NLM" IndexingMethod="Curated"><PMID Version="1">34558120</PMID><DateCompleted><Year>2022</Year><Month>03</Month><Day>11</Day></DateCompleted><DateRevised><Year>2023</Year><Month>02</Month><Day>02</Day></DateRevised><Article PubModel="Print-Electronic"><Journal><ISSN IssnType="Electronic">1098-1136</ISSN><JournalIssue CitedMedium="Internet"><Volume>70</Volume><Issue>2</Issue><PubDate><Year>2022</Year><Month>Feb</Month></PubDate></JournalIssue><Title>Glia</Title><ISOAbbreviation>Glia</ISOAbbreviation></Journal><ArticleTitle>Glial TDP-43 and TDP-43 induced glial pathology, focus on neurodegenerative proteinopathy syndromes.</ArticleTitle><Pagination><StartPage>239</StartPage><EndPage>255</EndPage><MedlinePgn>239-255</MedlinePgn></Pagination><ELocationID EIdType="doi" ValidYN="Y">10.1002/glia.24096</ELocationID><Abstract><AbstractText>Since its discovery in 2006, TAR DNA binding protein 43 (TDP-43) has driven rapidly evolving research in neurodegenerative diseases including amyotrophic lateral sclerosis (ALS), frontotemporal lobar degeneration (FTLD), and limbic predominant age-related TDP-43 encephalopathy (LATE). TDP-43 mislocalization or aggregation is the hallmark of TDP-43 proteinopathy and is associated with cognitive impairment that can be mapped to its regional deposition. Studies in human tissue and model systems demonstrate that TDP-43 may potentiate other proteinopathies such as the amyloid or tau pathology seen in Alzheimer's Disease (AD) in the combination of AD+LATE. Despite this growing body of literature, there remain gaps in our understanding of whether there is heterogeneity in TDP-43 driven mechanisms across cell types. The growing observations of correlation between TDP-43 proteinopathy and glial pathology suggest a relationship between the two, including pathogenic glial cell-autonomous dysfunction and dysregulated glial immune responses to neuronal TDP-43. In this review, we discuss the available data on TDP-43 in glia within the context of the neurodegenerative diseases ALS and FTLD and highlight the current lack of information about glial TDP-43 interaction in AD+LATE. TDP-43 has proven to be a significant modulator of cognitive and neuropathological outcomes. A deeper understanding of its role in diverse cell types may provide relevant insights into neurodegenerative syndromes.</AbstractText><CopyrightInformation>&#xa9; 2021 Wiley Periodicals LLC.</CopyrightInformation></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Prater</LastName><ForeName>Katherine E</ForeName><Initials>KE</Initials><Identifier Source="ORCID">0000-0001-8615-207X</Identifier><AffiliationInfo><Affiliation>Department of Neurology, University of Washington, Seattle, Washington, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Latimer</LastName><ForeName>Caitlin S</ForeName><Initials>CS</Initials><Identifier Source="ORCID">0000-0003-3727-4278</Identifier><AffiliationInfo><Affiliation>Division of Neuropathology, Department of Laboratory Medicine and Pathology, University of Washington, Seattle, Washington, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Jayadev</LastName><ForeName>Suman</ForeName><Initials>S</Initials><Identifier Source="ORCID">0000-0003-3164-9665</Identifier><AffiliationInfo><Affiliation>Department of Neurology, University of Washington, Seattle, Washington, USA.</Affiliation></AffiliationInfo></Author></AuthorList><Language>eng</Language><GrantList CompleteYN="Y"><Grant><GrantID>RF1 AG063540</GrantID><Acronym>AG</Acronym><Agency>NIA NIH HHS</Agency><Country>United States</Country></Grant><Grant><GrantID>P30 AG066509</GrantID><Acronym>AG</Acronym><Agency>NIA NIH HHS</Agency><Country>United States</Country></Grant><Grant><GrantID>K08 AG065426</GrantID><Acronym>AG</Acronym><Agency>NIA NIH HHS</Agency><Country>United States</Country></Grant><Grant><GrantID>R01 NS073848</GrantID><Acronym>NS</Acronym><Agency>NINDS NIH HHS</Agency><Country>United States</Country></Grant></GrantList><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType><PublicationType UI="D052061">Research Support, N.I.H., Extramural</PublicationType><PublicationType UI="D016454">Review</PublicationType></PublicationTypeList><ArticleDate DateType="Electronic"><Year>2021</Year><Month>09</Month><Day>24</Day></ArticleDate></Article><MedlineJournalInfo><Country>United States</Country><MedlineTA>Glia</MedlineTA><NlmUniqueID>8806785</NlmUniqueID><ISSNLinking>0894-1491</ISSNLinking></MedlineJournalInfo><ChemicalList><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="D004268">DNA-Binding Proteins</NameOfSubstance></Chemical><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="C000598624">TARDBP protein, human</NameOfSubstance></Chemical></ChemicalList><CitationSubset>IM</CitationSubset><MeshHeadingList><MeshHeading><DescriptorName UI="D000690" MajorTopicYN="Y">Amyotrophic Lateral Sclerosis</DescriptorName><QualifierName UI="Q000473" MajorTopicYN="N">pathology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D004268" MajorTopicYN="N">DNA-Binding Proteins</DescriptorName><QualifierName UI="Q000378" MajorTopicYN="Y">metabolism</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D057174" MajorTopicYN="Y">Frontotemporal Lobar Degeneration</DescriptorName><QualifierName UI="Q000235" MajorTopicYN="N">genetics</QualifierName><QualifierName UI="Q000378" MajorTopicYN="N">metabolism</QualifierName><QualifierName UI="Q000473" MajorTopicYN="N">pathology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D009457" MajorTopicYN="N">Neuroglia</DescriptorName><QualifierName UI="Q000378" MajorTopicYN="N">metabolism</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D013577" MajorTopicYN="N">Syndrome</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D057177" MajorTopicYN="Y">TDP-43 Proteinopathies</DescriptorName><QualifierName UI="Q000473" MajorTopicYN="N">pathology</QualifierName></MeshHeading></MeshHeadingList><KeywordList Owner="NOTNLM"><Keyword MajorTopicYN="N">Alzheimer's disease</Keyword><Keyword MajorTopicYN="N">TDP-43</Keyword><Keyword MajorTopicYN="N">amyotrophic lateral sclerosis</Keyword><Keyword MajorTopicYN="N">astrocyte</Keyword><Keyword MajorTopicYN="N">frontotemporal lobar degeneration</Keyword><Keyword MajorTopicYN="N">glia</Keyword><Keyword MajorTopicYN="N">microglia</Keyword><Keyword MajorTopicYN="N">oligodendrocyte</Keyword></KeywordList></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="revised"><Year>2021</Year><Month>8</Month><Day>21</Day></PubMedPubDate><PubMedPubDate PubStatus="received"><Year>2021</Year><Month>4</Month><Day>5</Day></PubMedPubDate><PubMedPubDate PubStatus="accepted"><Year>2021</Year><Month>9</Month><Day>9</Day></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2021</Year><Month>9</Month><Day>25</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2022</Year><Month>3</Month><Day>12</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2021</Year><Month>9</Month><Day>24</Day><Hour>7</Hour><Minute>25</Minute></PubMedPubDate></History><PublicationStatus>ppublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">34558120</ArticleId><ArticleId IdType="mid">NIHMS1756958</ArticleId><ArticleId IdType="pmc">PMC8722378</ArticleId><ArticleId IdType="doi">10.1002/glia.24096</ArticleId></ArticleIdList><ReferenceList><Reference><Citation>Abramzon YA, Fratta P, Traynor BJ, Chia R. 2020. The Overlapping Genetics of Amyotrophic Lateral Sclerosis and Frontotemporal Dementia. Front Neurosci 14:42.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7012787</ArticleId><ArticleId IdType="pubmed">32116499</ArticleId></ArticleIdList></Reference><Reference><Citation>Allen NJ, Barres BA. 2009. Neuroscience: Glia - more than just brain glue. Nature 457:675&#x2013;677.</Citation><ArticleIdList><ArticleId IdType="pubmed">19194443</ArticleId></ArticleIdList></Reference><Reference><Citation>Amador-Ortiz C, Lin W-L, Ahmed Z, Personett D, Davies P, Duara R, Graff-Radford NR, Hutton ML, Dickson DW. 2007. TDP-43 immunoreactivity in hippocampal sclerosis and Alzheimer&#x2019;s disease. Annals of Neurology 61:435&#x2013;445.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC2677204</ArticleId><ArticleId IdType="pubmed">17469117</ArticleId></ArticleIdList></Reference><Reference><Citation>Amador-Ortiz C, Lin W-L, Ahmed Z, Personett D, Davies P, Duara R, Graff-Radford NR, Hutton ML, Dickson DW. 2007. TDP-43 immunoreactivity in hippocampal sclerosis and Alzheimer&#x2019;s disease. Ann Neurol 61:435&#x2013;445.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC2677204</ArticleId><ArticleId IdType="pubmed">17469117</ArticleId></ArticleIdList></Reference><Reference><Citation>Andrea R, Ilaria V, Jos&#xe9; JRA, Arthur B. 2016. Decreased Regenerative Capacity of Oligodendrocyte Progenitor Cells (NG2-Glia) in the Ageing Brain: A Vicious Cycle of Synaptic Dysfunction, Myelin Loss and Neuronal Disruption? Current Alzheimer Research 13:413&#x2013;418.</Citation><ArticleIdList><ArticleId IdType="pubmed">26567743</ArticleId></ArticleIdList></Reference><Reference><Citation>Arai T, Hasegawa M, Akiyama H, Ikeda K, Nonaka T, Mori H, Mann D, Tsuchiya K, Yoshida M, Hashizume Y, Oda T. 2006. TDP-43 is a component of ubiquitin-positive tau-negative inclusions in frontotemporal lobar degeneration and amyotrophic lateral sclerosis. Biochemical and Biophysical Research Communications.</Citation><ArticleIdList><ArticleId IdType="pubmed">17084815</ArticleId></ArticleIdList></Reference><Reference><Citation>Arai T, Hasegawa M, Nonoka T, Kametani F, Yamashita M, Hosokawa M, Niizato K, Tsuchiya K, Kobayashi Z, Ikeda K, Yoshida M, Onaya M, Fujishiro H, Akiyama H. 2010. Phosphorylated and cleaved TDP-43 in ALS, FTLD and other neurodegenerative disorders and in cellular models of TDP-43 proteinopathy. Neuropathology 30:170&#x2013;181.</Citation><ArticleIdList><ArticleId IdType="pubmed">20102522</ArticleId></ArticleIdList></Reference><Reference><Citation>Augusto-Oliveira M, Arrifano GP, Lopes-Ara&#xfa;jo A, Santos-Sacramento L, Takeda PY, Anthony DC, Malva JO, Crespo-Lopez ME. 2019. What Do Microglia Really Do in Healthy Adult Brain? Cells 8:1293.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC6829860</ArticleId><ArticleId IdType="pubmed">31652490</ArticleId></ArticleIdList></Reference><Reference><Citation>Balka KR, Louis C, Saunders TL, Smith AM, Calleja DJ, D&#x2019;Silva DB, Moghaddas F, Tailler M, Lawlor KE, Zhan Y, Burns CJ, Wicks IP, Miner JJ, Kile BT, Masters SL, De Nardo D. 2020. TBK1 and IKK&#x3b5; Act Redundantly to Mediate STING-Induced NF-&#x3ba;B Responses in Myeloid Cells. Cell Reports 31:107492.</Citation><ArticleIdList><ArticleId IdType="pubmed">32268090</ArticleId></ArticleIdList></Reference><Reference><Citation>Barmada SJ, Skibinski G, Korb E, Rao EJ, Wu JY, Finkbeiner S. 2010. Cytoplasmic Mislocalization of TDP-43 Is Toxic to Neurons and Enhanced by a Mutation Associated with Familial Amyotrophic Lateral Sclerosis. J Neurosci 30:639&#x2013;649.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC2821110</ArticleId><ArticleId IdType="pubmed">20071528</ArticleId></ArticleIdList></Reference><Reference><Citation>Barton SK, Gregory JM, Chandran S, Turner BJ. 2019. Could an Impairment in Local Translation of mRNAs in Glia be Contributing to Pathogenesis in ALS?
Front Mol Neurosci [Internet] 12. Available from: https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6536688/</Citation><ArticleIdList><ArticleId IdType="pmc">PMC6536688</ArticleId><ArticleId IdType="pubmed">31164803</ArticleId></ArticleIdList></Reference><Reference><Citation>Bayram E, Shan G, Cummings JL. 2019. Associations between Comorbid TDP-43, Lewy Body Pathology, and Neuropsychiatric Symptoms in Alzheimer&#x2019;s Disease. J Alzheimers Dis 69:953&#x2013;961.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC6597983</ArticleId><ArticleId IdType="pubmed">31127776</ArticleId></ArticleIdList></Reference><Reference><Citation>Bhardwaj A, Myers MP, Buratti E, Baralle FE. 2013. Characterizing TDP-43 interaction with its RNA targets. Nucleic Acids Res 41:5062&#x2013;5074.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC3643599</ArticleId><ArticleId IdType="pubmed">23519609</ArticleId></ArticleIdList></Reference><Reference><Citation>de Boer EMJ, Orie VK, Williams T, Baker MR, De Oliveira HM, Polvikoski T, Silsby M, Menon P, van den Bos M, Halliday GM, van den Berg LH, Van Den Bosch L, van Damme P, Kiernan MC, van Es MA, Vucic S. 2020. TDP-43 proteinopathies: a new wave of neurodegenerative diseases. J Neurol Neurosurg Psychiatry 92:86&#x2013;95.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7803890</ArticleId><ArticleId IdType="pubmed">33177049</ArticleId></ArticleIdList></Reference><Reference><Citation>Bolognesi B, Faure AJ, Seuma M, Schmiedel JM, Tartaglia GG, Lehner B. 2019. The mutational landscape of a prion-like domain. Nat Commun [Internet] 10. Available from: https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6744496/</Citation><ArticleIdList><ArticleId IdType="pmc">PMC6744496</ArticleId><ArticleId IdType="pubmed">31519910</ArticleId></ArticleIdList></Reference><Reference><Citation>Brenowitz WD, Monsell SE, Schmitt FA, Kukull WA, Nelson PT. 2014. Hippocampal sclerosis of aging is a key Alzheimer&#x2019;s disease mimic: clinical-pathologic correlations and comparisons with both alzheimer&#x2019;s disease and non-tauopathic frontotemporal lobar degeneration. J Alzheimers Dis 39:691&#x2013;702.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC3946156</ArticleId><ArticleId IdType="pubmed">24270205</ArticleId></ArticleIdList></Reference><Reference><Citation>Brettschneider J, Arai K, Del Tredici K, Toledo JB, Robinson JL, Lee EB, Kuwabara S, Shibuya K, Irwin DJ, Fang L, Van Deerlin VM, Elman L, McCluskey L, Ludolph AC, Lee VM-Y, Braak H, Trojanowski JQ. 2014. TDP-43 pathology and neuronal loss in amyotrophic lateral sclerosis spinal cord. Acta Neuropathol 128:423&#x2013;437.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC4384652</ArticleId><ArticleId IdType="pubmed">24916269</ArticleId></ArticleIdList></Reference><Reference><Citation>Buratti E, D&#xf6;rk T, Zuccato E, Pagani F, Romano M, Baralle FE. 2001. Nuclear factor TDP-43 and SR proteins promote in vitro and in vivo CFTR exon 9 skipping. The EMBO Journal 20:1774&#x2013;1784.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC145463</ArticleId><ArticleId IdType="pubmed">11285240</ArticleId></ArticleIdList></Reference><Reference><Citation>Burrell JR, Halliday GM, Kril JJ, Ittner LM, G&#xf6;tz J, Kiernan MC, Hodges JR. 2016. The frontotemporal dementia-motor neuron disease continuum. Lancet 388:919&#x2013;931.</Citation><ArticleIdList><ArticleId IdType="pubmed">26987909</ArticleId></ArticleIdList></Reference><Reference><Citation>Butt AM, De La Rocha IC, Rivera A. 2019. Oligodendroglial Cells in Alzheimer&#x2019;s Disease. Adv Exp Med Biol 1175:325&#x2013;333.</Citation><ArticleIdList><ArticleId IdType="pubmed">31583593</ArticleId></ArticleIdList></Reference><Reference><Citation>Caccamo A, Magr&#xed; A, Oddo S. 2010. Age-dependent changes in TDP-43 levels in a mouse model of Alzheimer disease are linked to A&#x3b2; oligomers accumulation. Mol Neurodegener 5:51.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC2989316</ArticleId><ArticleId IdType="pubmed">21070634</ArticleId></ArticleIdList></Reference><Reference><Citation>Cai Z, Xiao M. 2016. Oligodendrocytes and Alzheimer&#x2019;s disease. International Journal of Neuroscience 126:97&#x2013;104.</Citation><ArticleIdList><ArticleId IdType="pubmed">26000818</ArticleId></ArticleIdList></Reference><Reference><Citation>Correia AS, Patel P, Dutta K, Julien J-P. 2015. Inflammation Induces TDP-43 Mislocalization and Aggregation. PLoS One [Internet] 10. Available from: https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4596857/</Citation><ArticleIdList><ArticleId IdType="pmc">PMC4596857</ArticleId><ArticleId IdType="pubmed">26444430</ArticleId></ArticleIdList></Reference><Reference><Citation>Deora V, Lee JD, Albornoz EA, McAlary L, Jagaraj CJ, Robertson AAB, Atkin JD, Cooper MA, Schroder K, Yerbury JJ, Gordon R, Woodruff TM. 2020. The microglial NLRP3 inflammasome is activated by amyotrophic lateral sclerosis proteins. Glia 68:407&#x2013;421.</Citation><ArticleIdList><ArticleId IdType="pubmed">31596526</ArticleId></ArticleIdList></Reference><Reference><Citation>De Strooper B, Karran E. 2016. The Cellular Phase of Alzheimer&#x2019;s Disease. Cell 164:603&#x2013;615.</Citation><ArticleIdList><ArticleId IdType="pubmed">26871627</ArticleId></ArticleIdList></Reference><Reference><Citation>Dewey CM, Cenik B, Sephton CF, Johnson BA, Herz J, Yu G. 2012. TDP-43 Aggregation In Neurodegeneration: Are Stress Granules The Key? Brain Res 1462:16&#x2013;25.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC3372581</ArticleId><ArticleId IdType="pubmed">22405725</ArticleId></ArticleIdList></Reference><Reference><Citation>Dickson DW, Baker M, Rademakers R. 2010. Common variant in GRN is a genetic risk factor for hippocampal sclerosis in the elderly. Neurodegener Dis 7:170&#x2013;174.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC2859236</ArticleId><ArticleId IdType="pubmed">20197700</ArticleId></ArticleIdList></Reference><Reference><Citation>Escartin C, Galea E, Lakatos A, O&#x2019;Callaghan JP, Petzold GC, Serrano-Pozo A, Steinh&#xe4;user C, Volterra A, Carmignoto G, Agarwal A, Allen NJ, Araque A, Barbeito L, Barzilai A, Bergles DE, Bonvento G, Butt AM, Chen W-T, Cohen-Salmon M, Cunningham C, Deneen B, De Strooper B, D&#xed;az-Castro B, Farina C, Freeman M, Gallo V, Goldman JE, Goldman SA, G&#xf6;tz M, Guti&#xe9;rrez A, Haydon PG, Heiland DH, Hol EM, Holt MG, Iino M, Kastanenka KV, Kettenmann H, Khakh BS, Koizumi S, Lee CJ, Liddelow SA, MacVicar BA, Magistretti P, Messing A, Mishra A, Molofsky AV, Murai KK, Norris CM, Okada S, Oliet SHR, Oliveira JF, Panatier A, Parpura V, Pekna M, Pekny M, Pellerin L, Perea G, P&#xe9;rez-Nievas BG, Pfrieger FW, Poskanzer KE, Quintana FJ, Ransohoff RM, Riquelme-Perez M, Robel S, Rose CR, Rothstein JD, Rouach N, Rowitch DH, Semyanov A, Sirko S, Sontheimer H, Swanson RA, Vitorica J, Wanner I-B, Wood LB, Wu J, Zheng B, Zimmer ER, Zorec R, Sofroniew MV, Verkhratsky A. 2021. Reactive astrocyte nomenclature, definitions, and future directions. Nat Neurosci 24:312&#x2013;325.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8007081</ArticleId><ArticleId IdType="pubmed">33589835</ArticleId></ArticleIdList></Reference><Reference><Citation>Escartin C, Guillemaud O, Sauvage M-AC. 2019. Questions and (some) answers on reactive astrocytes. Glia 67:2221&#x2013;2247.</Citation><ArticleIdList><ArticleId IdType="pubmed">31429127</ArticleId></ArticleIdList></Reference><Reference><Citation>Farrer MJ, Hulihan MM, Kachergus JM, D&#xe4;chsel JC, Stoessl AJ, Grantier LL, Calne S, Calne DB, Lechevalier B, Chapon F, Tsuboi Y, Yamada T, Gutmann L, Elibol B, Bhatia KP, Wider C, Vilari&#xf1;o-G&#xfc;ell C, Ross OA, Brown LA, Castanedes-Casey M, Dickson DW, Wszolek ZK. 2009. DCTN1 mutations in Perry syndrome. Nat Genet 41:163&#x2013;165.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC2813485</ArticleId><ArticleId IdType="pubmed">19136952</ArticleId></ArticleIdList></Reference><Reference><Citation>Feiler MS, Strobel B, Freischmidt A, Helferich AM, Kappel J, Brewer BM, Li D, Thal DR, Walther P, Ludolph AC, Danzer KM, Weishaupt JH. 2015. TDP-43 is intercellularly transmitted across axon terminals. J Cell Biol 211:897&#x2013;911.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC4657165</ArticleId><ArticleId IdType="pubmed">26598621</ArticleId></ArticleIdList></Reference><Reference><Citation>Femminella GD, Harold D, Scott J, Williams J, Edison P, Initiative for the ADN. 2020. The Differential Influence of Immune, Endocytotic, and Lipid Metabolism Genes on Amyloid Deposition and Neurodegeneration in Subjects at Risk of Alzheimer&#x2019;s Disease. Journal of Alzheimer&#x2019;s Disease Preprint:1&#x2013;13.</Citation><ArticleIdList><ArticleId IdType="pubmed">33216025</ArticleId></ArticleIdList></Reference><Reference><Citation>Foerster S, Hill MFE, Franklin RJM. 2019. Diversity in the oligodendrocyte lineage: Plasticity or heterogeneity? Glia 67:1797&#x2013;1805.</Citation><ArticleIdList><ArticleId IdType="pubmed">30968471</ArticleId></ArticleIdList></Reference><Reference><Citation>Friedman BA, Srinivasan K, Ayalon G, Meilandt WJ, Lin H, Huntley MA, Cao Y, Lee S-H, Haddick PCG, Ngu H, Modrusan Z, Larson JL, Kaminker JS, van der Brug MP, Hansen DV. 2018. Diverse Brain Myeloid Expression Profiles Reveal Distinct Microglial Activation States and Aspects of Alzheimer&#x2019;s Disease Not Evident in Mouse Models. Cell Reports 22:832&#x2013;847.</Citation><ArticleIdList><ArticleId IdType="pubmed">29346778</ArticleId></ArticleIdList></Reference><Reference><Citation>Gao J, Wang L, Gao C, Arakawa H, Perry G, Wang X. 2020. TDP-43 inhibitory peptide alleviates neurodegeneration and memory loss in an APP transgenic mouse model for Alzheimer&#x2019;s disease. Biochim Biophys Acta Mol Basis Dis 1866:165580.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC6861700</ArticleId><ArticleId IdType="pubmed">31678156</ArticleId></ArticleIdList></Reference><Reference><Citation>Gao J, Wang L, Huntley ML, Perry G, Wang X. 2018. Pathomechanisms of TDP-43 in neurodegeneration. J Neurochem.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC6110993</ArticleId><ArticleId IdType="pubmed">29486049</ArticleId></ArticleIdList></Reference><Reference><Citation>Gasset-Rosa F, Lu S, Yu H, Chen C, Melamed Z, Guo L, Shorter J, Da Cruz S, Cleveland DW. 2019. Cytoplasmic TDP-43 de-mixing independent of stress granules drives inhibition of nuclear import, loss of nuclear TDP-43, and cell death. Neuron 102:339&#x2013;357.e7.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC6548321</ArticleId><ArticleId IdType="pubmed">30853299</ArticleId></ArticleIdList></Reference><Reference><Citation>Gendron TF, Rademakers R, Petrucelli L. 2013. TARDBP mutation analysis in TDP-43 proteinopathies and deciphering the toxicity of mutant TDP-43. J Alzheimers Dis 33 Suppl 1:S35&#x2013;45.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC3532959</ArticleId><ArticleId IdType="pubmed">22751173</ArticleId></ArticleIdList></Reference><Reference><Citation>Gitcho MA, Baloh RH, Chakraverty S, Mayo K, Norton JB, Levitch D, Hatanpaa KJ, White CL, Bigio EH, Caselli R, Baker M, Al-Lozi MT, Morris JC, Pestronk A, Rademakers R, Goate AM, Cairns NJ. 2008. TDP-43 A315T Mutation in Familial Motor Neuron Disease. Ann Neurol 63:535&#x2013;538.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC2747362</ArticleId><ArticleId IdType="pubmed">18288693</ArticleId></ArticleIdList></Reference><Reference><Citation>Gitler AD, Shorter J. 2011. RNA-binding proteins with prion-like domains in ALS and FTLD-U. Prion 5:179&#x2013;187.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC3226045</ArticleId><ArticleId IdType="pubmed">21847013</ArticleId></ArticleIdList></Reference><Reference><Citation>Goedert M, Eisenberg DS, Crowther RA. 2017. Propagation of Tau Aggregates and Neurodegeneration. Annu Rev Neurosci 40:189&#x2013;210.</Citation><ArticleIdList><ArticleId IdType="pubmed">28772101</ArticleId></ArticleIdList></Reference><Reference><Citation>Gong C-X, Singh TJ, Grundke-Iqbal I, Iqbal K. 1993. Phosphoprotein Phosphatase Activities in Alzheimer Disease Brain. Journal of Neurochemistry 61:921&#x2013;927.</Citation><ArticleIdList><ArticleId IdType="pubmed">8395566</ArticleId></ArticleIdList></Reference><Reference><Citation>Gopinath A, Collins A, Khoshbouei H, Streit WJ. 2020. Microglia and Other Myeloid Cells in Central Nervous System Health and Disease. J Pharmacol Exp Ther 375:154&#x2013;160.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7569307</ArticleId><ArticleId IdType="pubmed">32238454</ArticleId></ArticleIdList></Reference><Reference><Citation>Gu J, Chen F, Iqbal K, Gong C-X, Wang X, Liu F. 2017. Transactive response DNA-binding protein 43 (TDP-43) regulates alternative splicing of tau exon 10: Implications for the pathogenesis of tauopathies. Journal of Biological Chemistry 292:10600&#x2013;10612.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC5481566</ArticleId><ArticleId IdType="pubmed">28487370</ArticleId></ArticleIdList></Reference><Reference><Citation>Gu J, Wang W, Miao S, Chen F, Wu F, Hu W, Iqbal K, Gong C-X, Liu F. 2018. Protein Phosphatase 1 dephosphorylates TDP-43 and suppresses its function in tau exon 10 inclusion. FEBS Letters 592:402&#x2013;410.</Citation><ArticleIdList><ArticleId IdType="pubmed">29334120</ArticleId></ArticleIdList></Reference><Reference><Citation>Haidet-Phillips AM, Hester ME, Miranda CJ, Meyer K, Braun L, Frakes A, Song S, Likhite S, Murtha MJ, Foust KD, Rao M, Eagle A, Kammesheidt A, Christensen A, Mendell JR, Burghes AHM, Kaspar BK. 2011. Astrocytes from Familial and Sporadic ALS Patients are Toxic to Motor Neurons. Nat Biotechnol 29:824&#x2013;828.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC3170425</ArticleId><ArticleId IdType="pubmed">21832997</ArticleId></ArticleIdList></Reference><Reference><Citation>Hebron M, Chen W, Miessau MJ, Lonskaya I, Moussa CE-H. 2014. Parkin reverses TDP-43-induced cell death and failure of amino acid homeostasis. J Neurochem 129:350&#x2013;361.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC3982293</ArticleId><ArticleId IdType="pubmed">24298989</ArticleId></ArticleIdList></Reference><Reference><Citation>Heneka MT, McManus RM, Latz E. 2018. Inflammasome signalling in brain function and neurodegenerative disease. Nature Reviews Neuroscience 19:610&#x2013;621.</Citation><ArticleIdList><ArticleId IdType="pubmed">30206330</ArticleId></ArticleIdList></Reference><Reference><Citation>Hergesheimer RC, Chami AA, de Assis DR, Vourc&#x2019;h P, Andres CR, Corcia P, Lanznaster D, Blasco H. 2019. The debated toxic role of aggregated TDP-43 in amyotrophic lateral sclerosis: a resolution in sight? Brain 142:1176&#x2013;1194.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC6487324</ArticleId><ArticleId IdType="pubmed">30938443</ArticleId></ArticleIdList></Reference><Reference><Citation>Herman AM, Khandelwal PJ, Rebeck GW, Moussa CE-H. 2012. Wild Type TDP-43 Induces Neuro-Inflammation and Alters APP Metabolism in Lentiviral Gene Transfer Models. Exp Neurol 235:297&#x2013;305.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC3434705</ArticleId><ArticleId IdType="pubmed">22402344</ArticleId></ArticleIdList></Reference><Reference><Citation>Herman AM, Khandelwal PJ, Stanczyk BB, Rebeck GW, Moussa CE-H. 2011. &#x3b2;-Amyloid triggers ALS-associated TDP-43 pathology in AD models. Brain Research 1386:191&#x2013;199.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC3073036</ArticleId><ArticleId IdType="pubmed">21376022</ArticleId></ArticleIdList></Reference><Reference><Citation>Heyburn L, Hebron ML, Smith J, Winston C, Bechara J, Li Z, Lonskaya I, Burns MP, Harris BT, Moussa CE-H. 2016. Tyrosine kinase inhibition reverses TDP-43 effects on synaptic protein expression, astrocytic function and amino acid dis-homeostasis. J Neurochem 139:610&#x2013;623.</Citation><ArticleIdList><ArticleId IdType="pubmed">27507246</ArticleId></ArticleIdList></Reference><Reference><Citation>Hunter S, Hokkanen SRK, Keage HAD, Fleming J, Minett T, Polvikoski T, Allinson K, Brayne C, the Cambridge City over 75s Cohort collaboration. 2020. TDP-43 Related Neuropathologies and Phosphorylation State: Associations with Age and Clinical Dementia in the Cambridge City over-75s Cohort. Journal of Alzheimer&#x2019;s Disease 75:337&#x2013;350.</Citation><ArticleIdList><ArticleId IdType="pubmed">32280087</ArticleId></ArticleIdList></Reference><Reference><Citation>Ikeda M, Ishikawa T, Tanabe H. 2004. Epidemiology of frontotemporal lobar degeneration. Dement Geriatr Cogn Disord 17:265&#x2013;268.</Citation><ArticleIdList><ArticleId IdType="pubmed">15178933</ArticleId></ArticleIdList></Reference><Reference><Citation>Jo M, Lee S, Jeon Y-M, Kim S, Kwon Y, Kim H-J. 2020. The role of TDP-43 propagation in neurodegenerative diseases: integrating insights from clinical and experimental studies. Exp Mol Med 52:1652&#x2013;1662.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8080625</ArticleId><ArticleId IdType="pubmed">33051572</ArticleId></ArticleIdList></Reference><Reference><Citation>Josephs KA, Dickson DW, Tosakulwong N, Weigand SD, Murray ME, Petrucelli L, Liesinger AM, Senjem ML, Spychalla AJ, Knopman DS, Parisi JE, Petersen RC, Jack CRJ, Whitwell JL. 2017. Rates of hippocampal atrophy and presence of post-mortem TDP-43 in patients with Alzheimer&#x2019;s disease: a longitudinal retrospective study. Lancet Neurol 16:917&#x2013;924.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC5646369</ArticleId><ArticleId IdType="pubmed">28919059</ArticleId></ArticleIdList></Reference><Reference><Citation>Josephs KA, Whitwell JL, Knopman DS, Hu WT, Stroh DA, Baker M, Rademakers R, Boeve BF, Parisi JE, Smith GE, Ivnik RJ, Petersen RC, Jack CRJ, Dickson DW. 2008. Abnormal TDP-43 immunoreactivity in AD modifies clinicopathologic and radiologic phenotype. Neurology 70:1850&#x2013;1857.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC2779031</ArticleId><ArticleId IdType="pubmed">18401022</ArticleId></ArticleIdList></Reference><Reference><Citation>Josephs KA, Whitwell JL, Weigand SD, Murray ME, Tosakulwong N, Liesinger AM, Petrucelli L, Senjem ML, Knopman DS, Boeve BF, Ivnik RJ, Smith GE, Jack CRJ, Parisi JE, Petersen RC, Dickson DW. 2014. TDP-43 is a key player in the clinical features associated with Alzheimer&#x2019;s disease. Acta Neuropathol 127:811&#x2013;824.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC4172544</ArticleId><ArticleId IdType="pubmed">24659241</ArticleId></ArticleIdList></Reference><Reference><Citation>Keren-Shaul H, Spinrad A, Weiner A, Matcovitch-Natan O, Dvir-Szternfeld R, Ulland TK, David E, Baruch K, Lara-Astaiso D, Toth B, Itzkovitz S, Colonna M, Schwartz M, Amit I. 2017. A Unique Microglia Type Associated with Restricting Development of Alzheimer&#x2019;s Disease. Cell 169:1276&#x2013;1290.e17.</Citation><ArticleIdList><ArticleId IdType="pubmed">28602351</ArticleId></ArticleIdList></Reference><Reference><Citation>Khalfallah Y, Kuta R, Grasmuck C, Prat A, Durham HD, Vande Velde C. 2018. TDP-43 regulation of stress granule dynamics in neurodegenerative disease-relevant cell types. Sci Rep [Internet] 8. Available from: https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5953947/</Citation><ArticleIdList><ArticleId IdType="pmc">PMC5953947</ArticleId><ArticleId IdType="pubmed">29765078</ArticleId></ArticleIdList></Reference><Reference><Citation>Kovacs GG. 2018. Understanding the Relevance of Aging-Related Tau Astrogliopathy (ARTAG). Neuroglia 1:339&#x2013;350.</Citation></Reference><Reference><Citation>LaClair KD, Donde A, Ling JP, Jeong YH, Chhabra R, Martin LJ, Wong PC. 2016. Depletion of TDP-43 decreases fibril and plaque &#x3b2;-amyloid and exacerbates neurodegeneration in an Alzheimer&#x2019;s mouse model. Acta Neuropathol 132:859&#x2013;873.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC5131701</ArticleId><ArticleId IdType="pubmed">27785573</ArticleId></ArticleIdList></Reference><Reference><Citation>Lagier-Tourenne C, Cleveland DW. 2009. Rethinking ALS: the FUS about TDP-43. Cell 136:1001&#x2013;1004.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC3110083</ArticleId><ArticleId IdType="pubmed">19303844</ArticleId></ArticleIdList></Reference><Reference><Citation>LaRocca TJ, Mariani A, Watkins LR, Link CD. 2019. TDP-43 knockdown causes innate immune activation via protein kinase R in astrocytes. Neurobiol Dis 132:104514.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC6834892</ArticleId><ArticleId IdType="pubmed">31229690</ArticleId></ArticleIdList></Reference><Reference><Citation>Latimer CS, Burke BT, Liachko NF, Currey HN, Kilgore MD, Gibbons LE, Henriksen J, Darvas M, Domoto-Reilly K, Jayadev S, Grabowski TJ, Crane PK, Larson EB, Kraemer BC, Bird TD, Keene CD. 2019. Resistance and resilience to Alzheimer&#x2019;s disease pathology are associated with reduced cortical pTau and absence of limbic-predominant age-related TDP-43 encephalopathy in a community-based cohort. Acta Neuropathol Commun [Internet] 7. Available from: https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6556006/</Citation><ArticleIdList><ArticleId IdType="pmc">PMC6556006</ArticleId><ArticleId IdType="pubmed">31174609</ArticleId></ArticleIdList></Reference><Reference><Citation>Leal-Lasarte MM, Franco JM, Labrador-Garrido A, Pozo D, Roodveldt C. 2017. Extracellular TDP-43 aggregates target MAPK/MAK/MRK overlapping kinase (MOK) and trigger caspase-3/IL-18 signaling in microglia. The FASEB Journal 31:2797&#x2013;2816.</Citation><ArticleIdList><ArticleId IdType="pubmed">28336525</ArticleId></ArticleIdList></Reference><Reference><Citation>Lee EB, Porta S, Michael Baer G, Xu Y, Suh E, Kwong LK, Elman L, Grossman M, Lee VM-Y, Irwin DJ, Van Deerlin VM, Trojanowski JQ. 2017. Expansion of the classification of FTLD-TDP: distinct pathology associated with rapidly progressive frontotemporal degeneration. Acta Neuropathol 134:65&#x2013;78.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC5521959</ArticleId><ArticleId IdType="pubmed">28130640</ArticleId></ArticleIdList></Reference><Reference><Citation>Lee S, Kim S, Kang H-Y, Lim HR, Kwon Y, Jo M, Jeon Y-M, Kim SR, Kim K, Ha CM, Lee S, Kim H-J. 2020. The overexpression of TDP-43 in astrocytes causes neurodegeneration via a PTP1B-mediated inflammatory response. J Neuroinflammation 17:299.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7556969</ArticleId><ArticleId IdType="pubmed">33054766</ArticleId></ArticleIdList></Reference><Reference><Citation>Lee Y, Morrison BM, Li Y, Lengacher S, Farah MH, Hoffman PN, Liu Y, Tsingalia A, Jin L, Zhang P-W, Pellerin L, Magistretti PJ, Rothstein JD. 2012. Oligodendroglia metabolically support axons and contribute to neurodegeneration. Nature 487:443&#x2013;448.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC3408792</ArticleId><ArticleId IdType="pubmed">22801498</ArticleId></ArticleIdList></Reference><Reference><Citation>Liddelow SA, Barres BA. 2017. Reactive Astrocytes: Production, Function, and Therapeutic Potential. Immunity 46:957&#x2013;967.</Citation><ArticleIdList><ArticleId IdType="pubmed">28636962</ArticleId></ArticleIdList></Reference><Reference><Citation>Ling S-C, Polymenidou M, Cleveland DW. 2013. Converging mechanisms in ALS and FTD: Disrupted RNA and protein homeostasis. Neuron 79:416&#x2013;438.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC4411085</ArticleId><ArticleId IdType="pubmed">23931993</ArticleId></ArticleIdList></Reference><Reference><Citation>Linnerbauer M, Rothhammer V. 2020. Protective Functions of Reactive Astrocytes Following Central Nervous System Insult. Front Immunol 11:573256.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7561408</ArticleId><ArticleId IdType="pubmed">33117368</ArticleId></ArticleIdList></Reference><Reference><Citation>Liscic RM, Grinberg LT, Zidar J, Gitcho MA, Cairns NJ. 2008. ALS and FTLD: two faces of TDP-43 proteinopathy. Eur J Neurol 15:772&#x2013;780.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC2801606</ArticleId><ArticleId IdType="pubmed">18684309</ArticleId></ArticleIdList></Reference><Reference><Citation>Liu R, Yang G, Nonaka T, Arai T, Jia W, Cynader MS. 2013. Reducing TDP-43 aggregation does not prevent its cytotoxicity. Acta Neuropathol Commun 1:49.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC3893365</ArticleId><ArticleId IdType="pubmed">24252504</ArticleId></ArticleIdList></Reference><Reference><Citation>Mackenzie IRA, Bigio EH, Ince PG, Geser F, Neumann M, Cairns NJ, Kwong LK, Forman MS, Ravits J, Stewart H, Eisen A, McClusky L, Kretzschmar HA, Monoranu CM, Highley JR, Kirby J, Siddique T, Shaw PJ, Lee VM-Y, Trojanowski JQ. 2007. Pathological TDP-43 distinguishes sporadic amyotrophic lateral sclerosis from amyotrophic lateral sclerosis with SOD1 mutations. Ann Neurol 61:427&#x2013;434.</Citation><ArticleIdList><ArticleId IdType="pubmed">17469116</ArticleId></ArticleIdList></Reference><Reference><Citation>Masaki K, Sonobe Y, Ghadge G, Pytel P, Roos RP. 2019. TDP-43 proteinopathy in Theiler&#x2019;s murine encephalomyelitis virus infection. PLoS Pathog 15:e1007574.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC6390522</ArticleId><ArticleId IdType="pubmed">30742696</ArticleId></ArticleIdList></Reference><Reference><Citation>Matej R, Tesar A, Rusina R. 2019. Alzheimer&#x2019;s disease and other neurodegenerative dementias in comorbidity: A clinical and neuropathological overview. Clin Biochem 73:26&#x2013;31.</Citation><ArticleIdList><ArticleId IdType="pubmed">31400306</ArticleId></ArticleIdList></Reference><Reference><Citation>Mathys H, Adaikkan C, Gao F, Young JZ, Manet E, Hemberg M, De Jager PL, Ransohoff RM, Regev A, Tsai L-H. 2017. Temporal Tracking of Microglia Activation in Neurodegeneration at Single-Cell Resolution. Cell Rep 21:366&#x2013;380.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC5642107</ArticleId><ArticleId IdType="pubmed">29020624</ArticleId></ArticleIdList></Reference><Reference><Citation>Mathys H, Davila-Velderrain J, Peng Z, Gao F, Mohammadi S, Young JZ, Menon M, He L, Abdurrob F, Jiang X, Martorell AJ, Ransohoff RM, Hafler BP, Bennett DA, Kellis M, Tsai L-H. 2019. Single-cell transcriptomic analysis of Alzheimer&#x2019;s disease. Nature 570:332&#x2013;337.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC6865822</ArticleId><ArticleId IdType="pubmed">31042697</ArticleId></ArticleIdList></Reference><Reference><Citation>McQuade A, Blurton-Jones M. 2019. Microglia in Alzheimer&#x2019;s Disease: Exploring How Genetics and Phenotype Influence Risk. Journal of Molecular Biology 431:1805&#x2013;1817.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC6475606</ArticleId><ArticleId IdType="pubmed">30738892</ArticleId></ArticleIdList></Reference><Reference><Citation>Montalbano M, McAllen S, Cascio FL, Sengupta U, Garcia S, Bhatt N, Ellsworth A, Heidelman EA, Johnson OD, Doskocil S, Kayed R. 2020. TDP-43 and Tau Oligomers in Alzheimer&#x2019;s Disease, Amyotrophic Lateral Sclerosis, and Frontotemporal Dementia. Neurobiology of Disease 146:105130.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7703712</ArticleId><ArticleId IdType="pubmed">33065281</ArticleId></ArticleIdList></Reference><Reference><Citation>Moszczynski AJ, Harvey M, Fulcher N, de Oliveira C, McCunn P, Donison N, Bartha R, Schmid S, Strong MJ, Volkening K. 2019. Synergistic toxicity in an in vivo model of neurodegeneration through the co-expression of human TDP-43 M337V and tau T175D protein. acta neuropathol commun 7:1&#x2013;17.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC6839082</ArticleId><ArticleId IdType="pubmed">31703746</ArticleId></ArticleIdList></Reference><Reference><Citation>Nasrabady SE, Rizvi B, Goldman JE, Brickman AM. 2018. White matter changes in Alzheimer&#x2019;s disease: a focus on myelin and oligodendrocytes. Acta Neuropathol Commun 6:22.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC5834839</ArticleId><ArticleId IdType="pubmed">29499767</ArticleId></ArticleIdList></Reference><Reference><Citation>Nelson PT, Abner EL, Schmitt FA, Kryscio RJ, Jicha GA, Smith CD, Davis DG, Poduska JW, Patel E, Mendiondo MS, Markesbery WR. 2010. Modeling the association between 43 different clinical and pathological variables and the severity of cognitive impairment in a large autopsy cohort of elderly persons. Brain Pathol 20:66&#x2013;79.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC2864342</ArticleId><ArticleId IdType="pubmed">19021630</ArticleId></ArticleIdList></Reference><Reference><Citation>Nelson PT, Dickson DW, Trojanowski JQ, Jack CR, Boyle PA, Arfanakis K, Rademakers R, Alafuzoff I, Attems J, Brayne C, Coyle-Gilchrist ITS, Chui HC, Fardo DW, Flanagan ME, Halliday G, Hokkanen SRK, Hunter S, Jicha GA, Katsumata Y, Kawas CH, Keene CD, Kovacs GG, Kukull WA, Levey AI, Makkinejad N, Montine TJ, Murayama S, Murray ME, Nag S, Rissman RA, Seeley WW, Sperling RA, White Iii CL, Yu L, Schneider JA. 2019a. Limbic-predominant age-related TDP-43 encephalopathy (LATE): consensus working group report. Brain : a journal of neurology.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC6536849</ArticleId><ArticleId IdType="pubmed">31039256</ArticleId></ArticleIdList></Reference><Reference><Citation>Nelson PT, Estus S, Abner EL, Parikh I, Malik M, Neltner JH, Ighodaro E, Wang W-X, Wilfred BR, Wang L-S, Kukull WA, Nandakumar K, Farman ML, Poon WW, Corrada MM, Kawas CH, Cribbs DH, Bennett DA, Schneider JA, Larson EB, Crane PK, Valladares O, Schmitt FA, Kryscio RJ, Jicha GA, Smith CD, Scheff SW, Sonnen JA, Haines JL, Pericak-Vance MA, Mayeux R, Farrer LA, Van Eldik LJ, Horbinski C, Green RC, Gearing M, Poon LW, Kramer PL, Woltjer RL, Montine TJ, Partch AB, Rajic AJ, Richmire K, Monsell SE, Alzheimer&#x2019; Disease Genetic Consortium, Schellenberg GD, Fardo DW. 2014. ABCC9 gene polymorphism is associated with hippocampal sclerosis of aging pathology. Acta Neuropathol 127:825&#x2013;843.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC4113197</ArticleId><ArticleId IdType="pubmed">24770881</ArticleId></ArticleIdList></Reference><Reference><Citation>Nelson PT, Gal Z, Wang W-X, Niedowicz DM, Artiushin SC, Wycoff S, Wei A, Jicha GA, Fardo DW. 2019b. TDP-43 proteinopathy in aging: Associations with risk-associated gene variants and with brain parenchymal thyroid hormone levels. Neurobiol Dis 125:67&#x2013;76.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC6696921</ArticleId><ArticleId IdType="pubmed">30682540</ArticleId></ArticleIdList></Reference><Reference><Citation>Nelson PT, Wang W-X, Partch AB, Monsell SE, Valladares O, Ellingson SR, Wilfred BR, Naj AC, Wang L-S, Kukull WA, Fardo DW. 2015. Reassessment of risk genotypes (GRN, TMEM106B, and ABCC9 variants) associated with hippocampal sclerosis of aging pathology. J Neuropathol Exp Neurol 74:75&#x2013;84.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC4270894</ArticleId><ArticleId IdType="pubmed">25470345</ArticleId></ArticleIdList></Reference><Reference><Citation>Neumann M, Kwong LK, Truax AC, Vanmassenhove B, Kretzschmar HA, Van Deerlin VM, Clark CM, Grossman M, Miller BL, Trojanowski JQ, Lee VM-Y. 2007. TDP-43-Positive White Matter Pathology in Frontotemporal Lobar Degeneration With Ubiquitin-Positive Inclusions. Journal of Neuropathology &amp; Experimental Neurology 66:177&#x2013;183.</Citation><ArticleIdList><ArticleId IdType="pubmed">17356379</ArticleId></ArticleIdList></Reference><Reference><Citation>Neumann M, Sampathu DM, Kwong LK, Truax AC, Micsenyi MC, Chou TT, Bruce J, Schuck T, Grossman M, Clark CM, McCluskey LF, Miller BL, Masliah E, Mackenzie IR, Feldman H, Feiden W, Kretzschmar HA, Trojanowski JQ, Lee VMY. 2006. Ubiquitinated TDP-43 in frontotemporal lobar degeneration and amyotrophic lateral sclerosis. Science.</Citation><ArticleIdList><ArticleId IdType="pubmed">17023659</ArticleId></ArticleIdList></Reference><Reference><Citation>Nguyen AT, Wang K, Hu G, Wang X, Miao Z, Azevedo JA, Suh E, Van Deerlin VM, Choi D, Roeder K, Li M, Lee EB. 2020. APOE and TREM2 regulate amyloid-responsive microglia in Alzheimer&#x2019;s disease. Acta Neuropathol 140:477&#x2013;493.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7520051</ArticleId><ArticleId IdType="pubmed">32840654</ArticleId></ArticleIdList></Reference><Reference><Citation>Nolan M, Scott C, Gamarallage MP, Lunn D, Carpenter K, McDonough E, Meyer D, Kaanumalle S, Santamaria-Pang A, Turner MR, Talbot K, Ansorge O. 2020. Quantitative patterns of motor cortex proteinopathy across ALS genotypes. Acta Neuropathol Commun [Internet] 8. Available from: https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7331195/</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7331195</ArticleId><ArticleId IdType="pubmed">32616036</ArticleId></ArticleIdList></Reference><Reference><Citation>Olney NT, Spina S, Miller BL. 2017. Frontotemporal Dementia. Neurol Clin 35:339&#x2013;374.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC5472209</ArticleId><ArticleId IdType="pubmed">28410663</ArticleId></ArticleIdList></Reference><Reference><Citation>Ou SH, Wu F, Harrich D, Garc&#xed;a-Mart&#xed;nez LF, Gaynor RB. 1995. Cloning and characterization of a novel cellular protein, TDP-43, that binds to human immunodeficiency virus type 1 TAR DNA sequence motifs. J Virol 69:3584&#x2013;3596.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC189073</ArticleId><ArticleId IdType="pubmed">7745706</ArticleId></ArticleIdList></Reference><Reference><Citation>Paolicelli RC, Jawaid A, Henstridge CM, Valeri A, Merlini M, Robinson JL, Lee EB, Rose J, Appel S, Lee VM-Y, Trojanowski JQ, Spires-Jones T, Schulz PE, Rajendran L. 2017. TDP-43 Depletion in Microglia Promotes Amyloid Clearance but Also Induces Synapse Loss. Neuron 95:297&#x2013;308.e6.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC5519492</ArticleId><ArticleId IdType="pubmed">28669544</ArticleId></ArticleIdList></Reference><Reference><Citation>Peng AYT, Agrawal I, Ho WY, Yen Y-C, Pinter AJ, Liu J, Phua QXC, Koh KB, Chang J-C, Sanford E, Man JHK, Wong P, Gutmann DH, Tucker-Kellogg G, Ling S-C. 2020. Loss of TDP-43 in astrocytes leads to motor deficits by triggering A1-like reactive phenotype and triglial dysfunction. PNAS 117:29101&#x2013;29112.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7682406</ArticleId><ArticleId IdType="pubmed">33127758</ArticleId></ArticleIdList></Reference><Reference><Citation>Philips T, Bento-Abreu A, Nonneman A, Haeck W, Staats K, Geelen V, Hersmus N, K&#xfc;sters B, Van Den Bosch L, Van Damme P, Richardson WD, Robberecht W. 2013. Oligodendrocyte dysfunction in the pathogenesis of amyotrophic lateral sclerosis. Brain 136:471&#x2013;482.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC3572934</ArticleId><ArticleId IdType="pubmed">23378219</ArticleId></ArticleIdList></Reference><Reference><Citation>Pickford F, Marcus J, Camargo LM, Xiao Q, Graham D, Mo J-R, Burkhardt M, Kulkarni V, Crispino J, Hering H, Hutton M. 2011. Progranulin Is a Chemoattractant for Microglia and Stimulates Their Endocytic Activity. Am J Pathol 178:284&#x2013;295.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC3070582</ArticleId><ArticleId IdType="pubmed">21224065</ArticleId></ArticleIdList></Reference><Reference><Citation>Pomerantz JL, Baltimore D. 1999. NF-kappaB activation by a signaling complex containing TRAF2, TANK and TBK1, a novel IKK-related kinase. EMBO J 18:6694&#x2013;6704.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC1171732</ArticleId><ArticleId IdType="pubmed">10581243</ArticleId></ArticleIdList></Reference><Reference><Citation>Pons AL, Higginbottom A, Cooper-Knock J, Alrafiah A, Alofi E, Kirby J, Shaw PJ, Wood JD, Highley JR. 2020. Oligodendrocyte pathology exceeds axonal pathology in white matter in human amyotrophic lateral sclerosis. The Journal of Pathology 251:262&#x2013;271.</Citation><ArticleIdList><ArticleId IdType="pubmed">32391572</ArticleId></ArticleIdList></Reference><Reference><Citation>Power MC, Mormino E, Soldan A, James BD, Yu L, Armstrong NM, Bangen KJ, Delano-Wood L, Lamar M, Lim YY, Nudelman K, Zahodne L, Gross AL, Mungas D, Widaman KF, Schneider J. 2018. Combined neuropathological pathways account for age-related risk of dementia. Ann Neurol 84:10&#x2013;22.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC6119518</ArticleId><ArticleId IdType="pubmed">29944741</ArticleId></ArticleIdList></Reference><Reference><Citation>Quadri M, Cossu G, Saddi V, Simons EJ, Murgia D, Melis M, Ticca A, Oostra BA, Bonifati V. 2011. Broadening the phenotype of TARDBP mutations: the TARDBP Ala382Thr mutation and Parkinson&#x2019;s disease in Sardinia. Neurogenetics 12:203&#x2013;209.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC3158341</ArticleId><ArticleId IdType="pubmed">21667065</ArticleId></ArticleIdList></Reference><Reference><Citation>Radford RA, Morsch M, Rayner SL, Cole NJ, Pountney DL, Chung RS. 2015. The established and emerging roles of astrocytes and microglia in amyotrophic lateral sclerosis and frontotemporal dementia. Front Cell Neurosci [Internet] 9. Available from: https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4621294/</Citation><ArticleIdList><ArticleId IdType="pmc">PMC4621294</ArticleId><ArticleId IdType="pubmed">26578880</ArticleId></ArticleIdList></Reference><Reference><Citation>Rangaraju S, Dammer EB, Raza SA, Rathakrishnan P, Xiao H, Gao T, Duong DM, Pennington MW, Lah JJ, Seyfried NT, Levey AI. 2018. Identification and therapeutic modulation of a proinflammatory subset of disease-associated-microglia in Alzheimer&#x2019;s disease. Mol Neurodegener [Internet] 13. Available from: https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5963076/</Citation><ArticleIdList><ArticleId IdType="pmc">PMC5963076</ArticleId><ArticleId IdType="pubmed">29784049</ArticleId></ArticleIdList></Reference><Reference><Citation>Ratti A, Buratti E. 2016. Physiological functions and pathobiology of TDP-43 and FUS/TLS proteins. Journal of neurochemistry 138 Suppl:95&#x2013;111.</Citation><ArticleIdList><ArticleId IdType="pubmed">27015757</ArticleId></ArticleIdList></Reference><Reference><Citation>Rayaprolu S, Fujioka S, Traynor S, Soto-Ortolaza AI, Petrucelli L, Dickson DW, Rademakers R, Boylan KB, Graff-Radford NR, Uitti RJ, Wszolek ZK, Ross OA. 2013. TARDBP mutations in Parkinson&#x2019;s disease. Parkinsonism Relat Disord 19:312&#x2013;315.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC3582838</ArticleId><ArticleId IdType="pubmed">23231971</ArticleId></ArticleIdList></Reference><Reference><Citation>Robinson JL, Porta S, Garrett FG, Zhang P, Xie SX, Suh E, Van Deerlin VM, Abner EL, Jicha GA, Barber JM, Lee VM-Y, Lee EB, Trojanowski JQ, Nelson PT. 2020. Limbic-predominant age-related TDP-43 encephalopathy differs from frontotemporal lobar degeneration. Brain 143:2844&#x2013;2857.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7526723</ArticleId><ArticleId IdType="pubmed">32830216</ArticleId></ArticleIdList></Reference><Reference><Citation>Saito ER, Miller JB, Harari O, Cruchaga C, Mihindukulasuriya KA, Kauwe JSK, Bikman BT. 2021. Alzheimer&#x2019;s disease alters oligodendrocytic glycolytic and ketolytic gene expression. Alzheimer&#x2019;s &amp; Dementia [Internet] n/a. Available from: 10.1002/alz.12310</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/alz.12310</ArticleId><ArticleId IdType="pmc">PMC8410881</ArticleId><ArticleId IdType="pubmed">33650792</ArticleId></ArticleIdList></Reference><Reference><Citation>Sakurai A, Makioka K, Fukuda T, Takatama M, Okamoto K. 2013. Accumulation of phosphorylated TDP-43 in the CNS of a patient with Cockayne syndrome. Neuropathology 33:673&#x2013;677.</Citation><ArticleIdList><ArticleId IdType="pubmed">23581709</ArticleId></ArticleIdList></Reference><Reference><Citation>Salter MW, Stevens B. 2017. Microglia emerge as central players in brain disease. Nat Med 23:1018&#x2013;1027.</Citation><ArticleIdList><ArticleId IdType="pubmed">28886007</ArticleId></ArticleIdList></Reference><Reference><Citation>Seeley WW. 2008. Selective functional, regional, and neuronal vulnerability in frontotemporal dementia. Curr Opin Neurol 21:701&#x2013;707.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC2909835</ArticleId><ArticleId IdType="pubmed">18989116</ArticleId></ArticleIdList></Reference><Reference><Citation>Sephton CF, Cenik C, Kucukural A, Dammer EB, Cenik B, Han Y, Dewey CM, Roth FP, Herz J, Peng J, Moore MJ, Yu G. 2011. Identification of Neuronal RNA Targets of TDP-43-containing Ribonucleoprotein Complexes*&#x2666;. Journal of Biological Chemistry 286:1204&#x2013;1215.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC3020728</ArticleId><ArticleId IdType="pubmed">21051541</ArticleId></ArticleIdList></Reference><Reference><Citation>Serio A, Bilican B, Barmada SJ, Ando DM, Zhao C, Siller R, Burr K, Haghi G, Story D, Nishimura AL, Carrasco MA, Phatnani HP, Shum C, Wilmut I, Maniatis T, Shaw CE, Finkbeiner S, Chandran S. 2013. Astrocyte pathology and the absence of non-cell autonomy in an induced pluripotent stem cell model of TDP-43 proteinopathy. Proc Natl Acad Sci U S A 110:4697&#x2013;4702.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC3607024</ArticleId><ArticleId IdType="pubmed">23401527</ArticleId></ArticleIdList></Reference><Reference><Citation>Shaerzadeh F, Phan L, Miller D, Dacquel M, Hachmeister W, Hansen C, Bechtle A, Tu D, Martcheva M, Foster TC, Kumar A, Streit WJ, Khoshbouei H. 2020. Microglia senescence occurs in both substantia nigra and ventral tegmental area. Glia 68:2228&#x2013;2245.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8356201</ArticleId><ArticleId IdType="pubmed">32275335</ArticleId></ArticleIdList></Reference><Reference><Citation>Shih Y-H, Tu L-H, Chang T-Y, Ganesan K, Chang W-W, Chang P-S, Fang Y-S, Lin Y-T, Jin L-W, Chen Y-R. 2020. TDP-43 interacts with amyloid-&#x3b2;, inhibits fibrillization, and worsens pathology in a model of Alzheimer&#x2019;s disease. Nat Commun [Internet] 11. Available from: https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7683652/</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7683652</ArticleId><ArticleId IdType="pubmed">33230138</ArticleId></ArticleIdList></Reference><Reference><Citation>Smethurst P, Risse E, Tyzack GE, Mitchell JS, Taha DM, Chen Y-R, Newcombe J, Collinge J, Sidle K, Patani R. 2020. Distinct responses of neurons and astrocytes to TDP-43 proteinopathy in amyotrophic lateral sclerosis. Brain 143:430&#x2013;440.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7009461</ArticleId><ArticleId IdType="pubmed">32040555</ArticleId></ArticleIdList></Reference><Reference><Citation>Smit T, Deshayes NAC, Borchelt DR, Kamphuis W, Middeldorp J, Hol EM. 2021. Reactive astrocytes as treatment targets in Alzheimer&#x2019;s disease&#x2014;Systematic review of studies using the APPswePS1dE9 mouse model. Glia [Internet] n/a. Available from: 10.1002/glia.23981</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/glia.23981</ArticleId><ArticleId IdType="pmc">PMC8247905</ArticleId><ArticleId IdType="pubmed">33634529</ArticleId></ArticleIdList></Reference><Reference><Citation>Spiller KJ, Restrepo CR, Khan T, Dominique MA, Fang TC, Canter RG, Roberts C, Miller KR, Ransohoff RM, Trojanowski JQ, Lee VM-Y. 2018. Microglia-mediated recovery from ALS-relevant motor neuron degeneration in a mouse model of TDP-43 proteinopathy. Nat Neurosci 21:329&#x2013;340.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC5857237</ArticleId><ArticleId IdType="pubmed">29463850</ArticleId></ArticleIdList></Reference><Reference><Citation>Sproviero D, La Salvia S, Giannini M, Crippa V, Gagliardi S, Bernuzzi S, Diamanti L, Ceroni M, Pansarasa O, Poletti A, Cereda C. 2018. Pathological Proteins Are Transported by Extracellular Vesicles of Sporadic Amyotrophic Lateral Sclerosis Patients. Front Neurosci [Internet] 12. Available from: https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6060258/</Citation><ArticleIdList><ArticleId IdType="pmc">PMC6060258</ArticleId><ArticleId IdType="pubmed">30072868</ArticleId></ArticleIdList></Reference><Reference><Citation>Srinivasan K, Friedman BA, Etxeberria A, Huntley MA, van der Brug MP, Foreman O, Paw JS, Modrusan Z, Beach TG, Serrano GE, Hansen DV. 2020. Alzheimer&#x2019;s Patient Microglia Exhibit Enhanced Aging and Unique Transcriptional Activation. Cell Reports 31:107843.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7422733</ArticleId><ArticleId IdType="pubmed">32610143</ArticleId></ArticleIdList></Reference><Reference><Citation>Suk TR, Rousseaux MWC. 2020. The role of TDP-43 mislocalization in amyotrophic lateral sclerosis. Mol Neurodegener [Internet] 15. Available from: https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7429473/</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7429473</ArticleId><ArticleId IdType="pubmed">32799899</ArticleId></ArticleIdList></Reference><Reference><Citation>Svahn AJ, Don EK, Badrock AP, Cole NJ, Graeber MB, Yerbury JJ, Chung R, Morsch M. 2018. Nucleo-cytoplasmic transport of TDP-43 studied in real time: impaired microglia function leads to axonal spreading of TDP-43 in degenerating motor neurons. Acta Neuropathol 136:445&#x2013;459.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC6096729</ArticleId><ArticleId IdType="pubmed">29943193</ArticleId></ArticleIdList></Reference><Reference><Citation>Swarup V, Phaneuf D, Dupr&#xe9; N, Petri S, Strong M, Kriz J, Julien J-P. 2011. Deregulation of TDP-43 in amyotrophic lateral sclerosis triggers nuclear factor &#x3ba;B&#x2013;mediated pathogenic pathways. J Exp Med 208:2429&#x2013;2447.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC3256969</ArticleId><ArticleId IdType="pubmed">22084410</ArticleId></ArticleIdList></Reference><Reference><Citation>Swift IJ, Bocchetta M, Benotmane H, Woollacott IOC, Shafei R, Rohrer JD. 2021. Variable clinical phenotype in TBK1 mutations: case report of a novel mutation causing primary progressive aphasia and review of the literature. Neurobiology of Aging 99:100.e9&#x2013;100.e15.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7907669</ArticleId><ArticleId IdType="pubmed">32980182</ArticleId></ArticleIdList></Reference><Reference><Citation>Tognatta R, Miller RH. 2016. Contribution of the oligodendrocyte lineage to CNS repair and neurodegenerative pathologies. Neuropharmacology 110:539&#x2013;547.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC5512544</ArticleId><ArticleId IdType="pubmed">27108096</ArticleId></ArticleIdList></Reference><Reference><Citation>Tollervey JR, Curk T, Rogelj B, Briese M, Cereda M, Kayikci M, Hortob&#xe1;gyi T, Nishimura AL, &#x17d;upunski V, Patani R, Chandran S, Rot G, Zupan B, Shaw CE, Ule J. 2011. Characterising the RNA targets and position-dependent splicing regulation by TDP-43; implications for neurodegenerative diseases. Nat Neurosci 14:452&#x2013;458.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC3108889</ArticleId><ArticleId IdType="pubmed">21358640</ArticleId></ArticleIdList></Reference><Reference><Citation>Tong J, Huang C, Bi F, Wu Q, Huang B, Liu X, Li F, Zhou H, Xia X-G. 2013. Expression of ALS-linked TDP-43 mutant in astrocytes causes non-cell-autonomous motor neuron death in rats. EMBO J 32:1917&#x2013;1926.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC3981181</ArticleId><ArticleId IdType="pubmed">23714777</ArticleId></ArticleIdList></Reference><Reference><Citation>Trivi&#xf1;o JJ, von Bernhardi R. 2021. The effect of aged microglia on synaptic impairment and its relevance in neurodegenerative diseases. Neurochem Int 144:104982.</Citation><ArticleIdList><ArticleId IdType="pubmed">33556444</ArticleId></ArticleIdList></Reference><Reference><Citation>Tziortzouda P, Van Den Bosch L, Hirth F. 2021. Triad of TDP43 control in neurodegeneration: autoregulation, localization and aggregation. Nature Reviews Neuroscience 22:197&#x2013;208.</Citation><ArticleIdList><ArticleId IdType="pubmed">33654312</ArticleId></ArticleIdList></Reference><Reference><Citation>Uryu K, Nakashima-Yasuda H, Forman MS, Kwong LK, Clark CM, Grossman M, Miller BL, Kretzschmar HA, Lee VM-Y, Trojanowski JQ, Neumann M. 2008. Concomitant TAR-DNA-binding protein 43 pathology is present in Alzheimer disease and corticobasal degeneration but not in other tauopathies. J Neuropathol Exp Neurol 67:555&#x2013;564.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC3659339</ArticleId><ArticleId IdType="pubmed">18520774</ArticleId></ArticleIdList></Reference><Reference><Citation>Van Damme P, Robberecht W. 2021. STING-Induced Inflammation &#x2014; A Novel Therapeutic Target in ALS? | NEJM. New England Journal of Medicine [Internet]. Available from: 10.1056/NEJMcibr2031048</Citation><ArticleIdList><ArticleId IdType="doi">10.1056/NEJMcibr2031048</ArticleId><ArticleId IdType="pubmed">33626258</ArticleId></ArticleIdList></Reference><Reference><Citation>Van Deerlin VM, Sleiman PMA, Martinez-Lage M, Chen-Plotkin A, Wang L-S, Graff-Radford NR, Dickson DW, Rademakers R, Boeve BF, Grossman M, Arnold SE, Mann DMA, Pickering-Brown SM, Seelaar H, Heutink P, van Swieten JC, Murrell JR, Ghetti B, Spina S, Grafman J, Hodges J, Spillantini MG, Gilman S, Lieberman AP, Kaye JA, Woltjer RL, Bigio EH, Mesulam M, Al-Sarraj S, Troakes C, Rosenberg RN, White CL, Ferrer I, Llad&#xf3; A, Neumann M, Kretzschmar HA, Hulette CM, Welsh-Bohmer KA, Miller BL, Alzualde A, Lopez de Munain A, McKee AC, Gearing M, Levey AI, Lah JJ, Hardy J, Rohrer JD, Lashley T, Mackenzie IRA, Feldman HH, Hamilton RL, Dekosky ST, van der Zee J, Kumar-Singh S, Van Broeckhoven C, Mayeux R, Vonsattel JPG, Troncoso JC, Kril JJ, Kwok JBJ, Halliday GM, Bird TD, Ince PG, Shaw PJ, Cairns NJ, Morris JC, McLean CA, DeCarli C, Ellis WG, Freeman SH, Frosch MP, Growdon JH, Perl DP, Sano M, Bennett DA, Schneider JA, Beach TG, Reiman EM, Woodruff BK, Cummings J, Vinters HV, Miller CA, Chui HC, Alafuzoff I, Hartikainen P, Seilhean D, Galasko D, Masliah E, Cotman CW, Tu&#xf1;&#xf3;n MT, Mart&#xed;nez MCC, Munoz DG, Carroll SL, Marson D, Riederer PF, Bogdanovic N, Schellenberg GD, Hakonarson H, et al. 2010. Common variants at 7p21 are associated with frontotemporal lobar degeneration with TDP-43 inclusions. Nat Genet 42:234&#x2013;239.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC2828525</ArticleId><ArticleId IdType="pubmed">20154673</ArticleId></ArticleIdList></Reference><Reference><Citation>Velebit J, Horvat A, Smoli&#x10d; T, Prpar Mihevc S, Rogelj B, Zorec R, Vardjan N. 2020. Astrocytes with TDP-43 inclusions exhibit reduced noradrenergic cAMP and Ca2+ signaling and dysregulated cell metabolism. Sci Rep [Internet] 10. Available from: https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7138839/</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7138839</ArticleId><ArticleId IdType="pubmed">32265469</ArticleId></ArticleIdList></Reference><Reference><Citation>Verkhratsky A, Nedergaard M. 2018. Physiology of Astroglia. Physiol Rev 98:239&#x2013;389.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC6050349</ArticleId><ArticleId IdType="pubmed">29351512</ArticleId></ArticleIdList></Reference><Reference><Citation>Walker AK, Daniels CML, Goldman JE, Trojanowski JQ, Lee VM-Y, Messing A. 2014. Astrocytic TDP-43 pathology in Alexander disease. J Neurosci 34:6448&#x2013;6458.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC4012304</ArticleId><ArticleId IdType="pubmed">24806671</ArticleId></ArticleIdList></Reference><Reference><Citation>Wang J, Ho WY, Lim K, Feng J, Tucker-Kellogg G, Nave K-A, Ling S-C. 2018. Cell-autonomous requirement of TDP-43, an ALS/FTD signature protein, for oligodendrocyte survival and myelination. Proc Natl Acad Sci U S A 115:E10941&#x2013;E10950.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC6243235</ArticleId><ArticleId IdType="pubmed">30373824</ArticleId></ArticleIdList></Reference><Reference><Citation>Wang W, Wang L, Lu J, Siedlak SL, Fujioka H, Liang J, Jiang S, Ma X, Jiang Z, da Rocha EL, Sheng M, Choi H, Lerou PH, Li H, Wang X. 2016. The Inhibition of TDP-43 Mitochondrial Localization Blocks Its Neuronal Toxicity. Nat Med 22:869&#x2013;878.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC4974139</ArticleId><ArticleId IdType="pubmed">27348499</ArticleId></ArticleIdList></Reference><Reference><Citation>Wilson RS, Capuano AW, Bennett DA, Schneider JA, Boyle PA. 2016. Temporal course of neurodegenerative effects on cognition in old age. Neuropsychology 30:591&#x2013;599.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC4988317</ArticleId><ArticleId IdType="pubmed">27111293</ArticleId></ArticleIdList></Reference><Reference><Citation>Winton MJ, Igaz LM, Wong MM, Kwong LK, Trojanowski JQ, Lee VM-Y. 2008. Disturbance of Nuclear and Cytoplasmic TAR DNA-binding Protein (TDP-43) Induces Disease-like Redistribution, Sequestration, and Aggregate Formation. J Biol Chem 283:13302&#x2013;13309.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC2442318</ArticleId><ArticleId IdType="pubmed">18305110</ArticleId></ArticleIdList></Reference><Reference><Citation>Woollacott IOC, Bocchetta M, Sudre CH, Ridha BH, Strand C, Courtney R, Ourselin S, Cardoso MJ, Warren JD, Rossor MN, Revesz T, Fox NC, Holton JL, Lashley T, Rohrer JD. 2018. Pathological correlates of white matter hyperintensities in a case of progranulin mutation associated frontotemporal dementia. Neurocase 24:166&#x2013;174.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC6168954</ArticleId><ArticleId IdType="pubmed">30112957</ArticleId></ArticleIdList></Reference><Reference><Citation>Yang C, Wang H, Qiao T, Yang B, Aliaga L, Qiu L, Tan W, Salameh J, McKenna-Yasek DM, Smith T, Peng L, Moore MJ, Brown RH, Cai H, Xu Z. 2014. Partial loss of TDP-43 function causes phenotypes of amyotrophic lateral sclerosis. Proc Natl Acad Sci U S A 111:E1121&#x2013;E1129.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC3970502</ArticleId><ArticleId IdType="pubmed">24616503</ArticleId></ArticleIdList></Reference><Reference><Citation>Yu C-H, Davidson S, Harapas CR, Hilton JB, Mlodzianoski MJ, Laohamonthonkul P, Louis C, Low RRJ, Moecking J, De Nardo D, Balka KR, Calleja DJ, Moghaddas F, Ni E, McLean CA, Samson AL, Tyebji S, Tonkin CJ, Bye CR, Turner BJ, Pepin G, Gantier MP, Rogers KL, McArthur K, Crouch PJ, Masters SL. 2020. TDP-43 Triggers Mitochondrial DNA Release via mPTP to Activate cGAS/STING in ALS. Cell 183:636&#x2013;649.e18.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7599077</ArticleId><ArticleId IdType="pubmed">33031745</ArticleId></ArticleIdList></Reference><Reference><Citation>Yu L, De Jager PL, Yang J, Trojanowski JQ, Bennett DA, Schneider JA. 2015. The TMEM106B locus and TDP-43 pathology in older persons without FTLD. Neurology 84:927&#x2013;934.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC4351662</ArticleId><ArticleId IdType="pubmed">25653292</ArticleId></ArticleIdList></Reference><Reference><Citation>Yu T, Yi Y-S, Yang Y, Oh J, Jeong D, Cho JY. 2012. The Pivotal Role of TBK1 in Inflammatory Responses Mediated by Macrophages. Mediators Inflamm [Internet] 2012. Available from: https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3523167/</Citation><ArticleIdList><ArticleId IdType="pmc">PMC3523167</ArticleId><ArticleId IdType="pubmed">23304064</ArticleId></ArticleIdList></Reference><Reference><Citation>Zamudio F, Loon AR, Smeltzer S, Benyamine K, Navalpur Shanmugam NK, Stewart NJF, Lee DC, Nash K, Selenica M-LB. 2020. TDP-43 mediated blood-brain barrier permeability and leukocyte infiltration promote neurodegeneration in a low-grade systemic inflammation mouse model. J Neuroinflammation 17:283.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7519496</ArticleId><ArticleId IdType="pubmed">32979923</ArticleId></ArticleIdList></Reference><Reference><Citation>Zhang P, Kishimoto Y, Grammatikakis loannis, Gottimukkala K, Cutler RG, Zhang S, Abdelmohsen K, Bohr VA, Sen JM, Gorospe M, Mattson MP. 2019. Senolytic therapy alleviates A&#x3b2;-associated oligodendrocyte progenitor cell senescence and cognitive deficits in an Alzheimer&#x2019;s disease model. Nat Neurosci 22:719&#x2013;728.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC6605052</ArticleId><ArticleId IdType="pubmed">30936558</ArticleId></ArticleIdList></Reference><Reference><Citation>Zhao W, Beers DR, Bell S, Wang J, Wen S, Baloh RH, Appel SH. 2015. TDP-43 activates microglia through NF-&#x3ba;B and NLRP3 inflammasome. Experimental Neurology 273:24&#x2013;35.</Citation><ArticleIdList><ArticleId IdType="pubmed">26222336</ArticleId></ArticleIdList></Reference></ReferenceList></PubmedData></PubmedArticle></PubmedArticleSet>